Heron Therapeutics, Inc.

NASDAQ:HRTX

1.58 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987
Revenue 127.044107.67286.34688.638145.96877.47430.7671.27900000.6461.3011.2610.3690.41205.3915.4044.8485.8154.3873.36620.42018.318.716.115.919.97.32.82.42.82.51.7
Cost of Revenue 65.10554.87446.02136.18961.61927.5124.5880.0350.73454.83330.91614.0750000000000.4450.440.6136.45.769.49.8911.63.81.11.20.70.60.4
Gross Profit 61.93952.79840.32552.44984.34949.96226.1791.244-0.734-54.833-30.916-14.0750.6461.3011.2610.3690.41205.3915.4044.8485.373.9472.7531414.312.39.36.36.98.33.51.71.22.11.91.3
Gross Profit Ratio 0.4880.490.4670.5920.5780.6450.8510.97300001111101110.9230.90.8180.6860.7150.6720.4970.3910.4340.4170.4790.6070.50.750.760.765
Reseach & Development Expenses 55.897107.506130.821174.533167.382140.032138.582103.12561.18354.83332.7815.0458.2077.2647.79619.50719.36415.23610.29911.4958.666.6997.3483.7134.34.43.73.54.16.30000000
General & Administrative Expenses 49.01437.43740.15342.22637.89729.26325.55421.36635.74219.72821.6778.7863.5013.9713.7074.3074.6813.6283.5653.2252.83.4953.3023.4636.567.411.49.600000000
Selling & Marketing Expenses 67.64382.51387.17963.85389.76464.60456.60147.66817.3478.708000000000000000000000000000
SG&A 116.657119.95127.332106.079127.66193.86782.15569.03435.74219.72821.6778.7863.5013.9713.7074.3074.6813.6283.5653.2252.83.4953.3023.4636.567.411.49.68.517.58.84.95.16.76.94.5
Other Expenses 0-7.366-2.8550.8855.9455.097-0.038-2.228-0.666-1.8060000000000000-0.1170.51.41.21.41.21.11.21.10.80.80.70.90.9
Operating Expenses 172.554227.456258.153280.612295.043233.899220.737172.15996.92574.56154.45723.83111.70811.23511.50323.81424.04518.86413.86414.7211.4610.19410.657.05911.311.812.316.314.915.918.79.95.75.97.47.85.4
Operating Income -110.615-174.658-217.828-228.163-210.694-183.937-194.558-170.915-96.925-74.561-54.457-23.831-11.062-9.934-10.242-23.445-23.633-18.864-8.473-9.316-6.612-4.824-6.703-4.3072.72.5-0.3-7-8.6-9-10.4-6.4-4-4.7-5.3-5.9-4.1
Operating Income Ratio -0.871-1.622-2.523-2.574-1.443-2.374-6.324-133.6320000-17.124-7.636-8.122-63.537-57.3620-1.572-1.724-1.364-0.83-1.528-1.280.1320.125-0.016-0.374-0.534-0.566-0.523-0.877-1.429-1.958-1.893-2.36-2.412
Total Other Income Expenses Net 0.056-7.366-2.8550.8855.9455.097-2.926-2.228-0.666-1.806-0.826-0.599-0.3732.7380.0240.523.83324.3810.290.2240.1530.2970.7130.02600.20.30.4-0.2-0.30.90.6010.91.10.5
Income Before Tax -110.559-182.024-220.683-227.278-204.749-178.84-197.484-173.143-97.591-76.367-55.283-24.43-11.435-7.196-10.15-23.125-19.85.517-8.47-9.294-6.459-4.756-6.617-4.28102.70-8.1-8.8-9.3-9.5-5.8-4-3.7-4.4-4.8-3.6
Income Before Tax Ratio -0.87-1.691-2.556-2.564-1.403-2.308-6.419-135.3740000-17.701-5.531-8.049-62.669-48.0580-1.571-1.72-1.332-0.818-1.508-1.27200.1350-0.433-0.547-0.585-0.477-0.795-1.429-1.542-1.571-1.92-2.118
Income Tax Expense 0-47.508-3.021-2.8471.8727.7693.899-1.099-0.734-0.578-0.333-1.2790.379-2.588-0.122-0.320.0410.119-0.263-0.095-2.249-1.046-4.19-12.8590.30.60.72.40.80.8-0.5-0.20.3-0.8-0.8-0.9-0.3
Net Income -110.559-134.516-217.662-224.431-204.749-178.84-197.484-173.143-97.591-76.367-55.283-23.348-11.814-7.346-10.028-23.125-20.1635.266-8.21-9.221-4.363-3.778-2.5148.5522.41.9-0.7-9.4-9.4-9.8-9.9-5.6-4.3-3.9-4.5-5-3.8
Net Income Ratio -0.87-1.249-2.521-2.532-1.403-2.308-6.419-135.3740000-18.288-5.646-7.952-62.669-48.9390-1.523-1.706-0.9-0.65-0.5732.5410.1180.095-0.038-0.503-0.584-0.616-0.497-0.767-1.536-1.625-1.607-2-2.235
EPS -0.8-1.24-2.21-2.47-2.5-2.44-3.65-4.57-2.95-2.87-3.42-1.91-1.96-3.7-6.15-15.01-20.8366.7-26.15-32.2-16.98-14.81-9.9233.69.610.4-2.88-40.96-45.69-48.87-58.03-34.5-34.4-32.14-37.86-43.99-35.08
EPS Diluted -0.8-1.24-2.21-2.47-2.5-2.44-3.65-4.57-2.95-2.87-3.42-1.91-1.96-3.7-6.15-15.01-20.8366.25-26.15-32.2-16.98-14.81-9.9233.69.69.6-2.88-40.96-45.69-48.87-58.03-34.5-34.4-32.14-37.86-43.99-35.08
EBITDA -103.792-176.661-215.252-222.53-201.233-174.655-192.016-169.38-96.191-73.983-54.457-23.831-10.883-6.967-9.862-22.513-19.4415.911-8.027-9.024-5.959-4.582-6.769-4.034-1.5-2-0.8-7.1-7.4-7.9-9.2-5.3-3.2-3.9-4.6-5-3.2
EBITDA Ratio -0.817-1.622-2.523-2.574-1.429-2.374-6.241-133.6320000-16.847-9.567-7.836-62.238-62.7450-1.49-1.67-1.301-0.758-1.455-1.3220.1570.1850.049-0.241-0.447-0.478-0.508-0.836-1.286-2.042-1.964-2.44-2.176